These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 18367830)
1. The diversity in clinical presentation of acquired factor V inhibitor. Two case reports. Gadelha T; Aquino JH; Assunção e Silva E; Santos FL; de Oliveira MH Acta Haematol; 2008; 119(2):108-10. PubMed ID: 18367830 [No Abstract] [Full Text] [Related]
3. Thrombin generation assay in a patient with acquired factor V inhibitor. Kindler S; Siegemund T; Führer D; Petros S J Thromb Haemost; 2008 Nov; 6(11):1985-7. PubMed ID: 18783483 [No Abstract] [Full Text] [Related]
4. [Acquired factor V inhibitor treated with intravenous immunoglobulins]. Buclin T; Schmidt PM; Hauert J; Winkel L; Chapuis G; Bachmann F Schweiz Med Wochenschr; 1992 Dec; 122(51-52):1968-70. PubMed ID: 1475662 [TBL] [Abstract][Full Text] [Related]
5. Spectrum of bleeding in acquired factor V inhibitor: a summary of 33 cases. Wiwanitkit V Clin Appl Thromb Hemost; 2006 Oct; 12(4):485-8. PubMed ID: 17000894 [TBL] [Abstract][Full Text] [Related]
7. [Acquired coagulation abnormality due to factor V inhibitor]. Iino N; Maruyama H; Gejyo F Nihon Naika Gakkai Zasshi; 2002 Nov; 91(11):3295-7. PubMed ID: 12652782 [No Abstract] [Full Text] [Related]
8. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors. de Raucourt E; Barbier C; Sinda P; Dib M; Peltier JY; Ternisien C Am J Hematol; 2003 Nov; 74(3):187-90. PubMed ID: 14587047 [TBL] [Abstract][Full Text] [Related]
9. Haemodialysis Tunisian patient with acquired factor V inhibitor associated to arteriovenous shunt thrombosis. Ghachem I; El Borgi W; Fekih Salem S; Ben Lakhal F; Chelbi A; Ghiriani I; Gouider E Ann Biol Clin (Paris); 2020 Apr; 78(2):206-209. PubMed ID: 32319951 [TBL] [Abstract][Full Text] [Related]
10. [Hereditary factor V deficiency and factor V inhibitor without bleeding. Rare causes of pathological screening tests of coagulation]. Borucki K; Töpfer G; Hartung KJ; Lutze G Hamostaseologie; 2007 Aug; 27(3):188-90. PubMed ID: 17694226 [TBL] [Abstract][Full Text] [Related]
11. Factor V inhibitor: case report. Leus B; Devreese K; van den Bossche J; Malfait R Blood Coagul Fibrinolysis; 2006 Oct; 17(7):585-7. PubMed ID: 16988556 [TBL] [Abstract][Full Text] [Related]
12. A case report of an acquired inhibitor to coagulation factor V. Shanmugam H; Jayaranee S; Eow GI Haemophilia; 2011 Jan; 17(1):168-70. PubMed ID: 20557356 [No Abstract] [Full Text] [Related]
13. Acquired factor V inhibitor and single exposure to autologous growth factor. Shah AK; Moreno-Aspitia A Thromb Res; 2005; 116(1):87-9. PubMed ID: 15850612 [No Abstract] [Full Text] [Related]
14. Development of cephradine-induced acquired factor V inhibitors: a case report. Wu MT; Pei SN Ann Pharmacother; 2010 Oct; 44(10):1673-6. PubMed ID: 20807866 [TBL] [Abstract][Full Text] [Related]
15. Severe bleeding caused by an inhibitor to coagulation factor V: a case report. Smid WM; de Wolf JT; Nijland JH; Bom VJ; van der Meer J Blood Coagul Fibrinolysis; 1994 Feb; 5(1):133-7. PubMed ID: 8180333 [TBL] [Abstract][Full Text] [Related]
16. [High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors]. Shimizu I; Ichikawa N; Yotsumoto M; Sumi M; Ueno M; Kobayashi H Rinsho Ketsueki; 2008 Jun; 49(6):413-6. PubMed ID: 18646609 [TBL] [Abstract][Full Text] [Related]
17. [Acquired factor V inhibitor: etiology, bleeding risk and therapeutic management with regard to three cases]. Schleinitz N; Veit V; Chouquet D; Seux V; Arnoux D; Mokart D; Lelong B; Alessi MC; Kaplanski G; Harlé JR Rev Med Interne; 2001 Nov; 22(11):1119-23. PubMed ID: 11817124 [TBL] [Abstract][Full Text] [Related]